HL
GILD icon

HeadInvest LLC’s Gilead Sciences GILD Stock Holding History

HeadInvest LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-550
Closed -$40.8K – 397
2023
Q3 		$40.8K Buy
+550
New +$42.3K 0.01% 374
2020
Q3 		– Sell
-2,993
Closed -$230K – 187
2020
Q2 		$230K Buy
2,993
+165
+6% +$12.6K 0.07% 161
2020
Q1 		$211K Buy
+2,828
New +$195K 0.08% 147

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HeadInvest LLC's GILD Position: Q4 2023 in Review

HeadInvest LLC sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 550 shares — an estimated $40.8K sold.

HeadInvest LLC first reported a position in GILD in Q1 2020 and held it in 3 quarters. The position peaked at $230K in Q2 2020. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • HeadInvest LLC reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • HeadInvest LLC sold 550 Gilead Sciences shares in Q4 2023, an estimated $40.8K.
  • HeadInvest LLC first reported a position in Gilead Sciences in Q1 2020 and held it in 3 quarters.
  • HeadInvest LLC's Gilead Sciences position peaked at $230K in Q2 2020.
  • 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on HeadInvest LLC's 13F filing for Q4 2023, filed 12 Feb 2024.